1. Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
   Liyuan Cao et al, 2021, Pharmacological Research CrossRef
2. Cyclo(Val-Pro) and Cyclo(Leu-Hydroxy-Pro) from Pseudomonas sp. (ABS-36) alleviates acute and chronic renal injury under in vitro and in vivo models (Ischemic reperfusion and unilateral ureter obstruction)
   Kirti Hira et al, 2022, International Immunopharmacology CrossRef
3. An in vitro evaluation of the antioxidant activities of necroptosis and apoptosis inhibitors: the potential of necrostatin-1 and necrostatin-1i to have radical scavenging activities
   Hironori Ushijima et al, 2023, Pharmacological Reports CrossRef
4. Necrostatin-1 attenuates sepsis-associated acute kidney injury by promoting autophagosome elimination in renal tubular epithelial cells
   Wei Dong et al, 2017, Molecular Medicine Reports CrossRef
5. Necrostatin‐1 mitigates renal ischaemia–reperfusion injury ‐ time dependent ‐ via aborting the interacting protein kinase (RIPK‐1)‐induced inflammatory immune response
   Hend Ashour et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
6. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells
   Anna Negroni et al, 2017, Digestive and Liver Disease CrossRef